ProclaimRx Launches AI Platform for Pharmaceutical Commercial Intelligence
ProclaimRx has launched an enterprise-grade AI platform that converts complex pharmaceutical data into real-time, decision-ready insights, announced in a press release. The platform, powered by the PLAiTO Intelligence Engine, aims to replace manual analysis processes with automated intelligence to help commercial teams optimize investments, target customers, and analyze performance within minutes.
The company stated that the platform can automate brand and sales data analysis, reclaiming up to 15 hours per week, and supports investment decisions through on-demand simulations and modeling. It also provides access to proprietary benchmarks and insights while maintaining enterprise-level data security.
As part of the launch, ProclaimRx appointed Eugene Lee as Chief Commercial Officer and Kathy Contratto as Vice President of Customer Operations. Both bring extensive experience in healthcare and life sciences leadership roles. The company will showcase live demos and host an interactive panel at the Pharma CX Marketing Summit in Philadelphia on October 20–21, 2025.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 22 Ping An Good Doctor Tests AI Medical Translation Service in Shenzhen Sep 22 Cellular Intelligence Adds Yann LeCun and Three Scientists to Advisory Board Sep 22 Amigo Rebrands as Concurrence Sep 22 CIPRA.ai and Murata Explore AI Wearables for Chronic Care Sep 22 CentralReach Releases ReportDraftAI for ABA ReportingLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Profound Raises $180 Million at $1.8 Billion Valuation
CluePoints Releases Three AI Tools for Clinical Data Review
Amigo Rebrands as Concurrence
Systech Launches TraceIQ for Pharmaceutical Supply Chains
Predoc Launches Curated Data Layer for Medical Records
Daily AI Brief: the AI news that matters, in your inbox.